Abstract
The clinical features are reported in 27 cases of ‘magic mushroom’ ingestion. Mydriasis and hyperreflexia were common as were disorders of perception and affect. Psilocybe semilanceata appears to have been the species of fungus involved.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cooles P. Abuse of the mushroom Panaeolus foenisecii. Br Med J. 1980 Feb 16;280(6212):446–447. doi: 10.1136/bmj.280.6212.446-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOFMANN A., HEIM R., BRACK A., KOBEL H. Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe mexicana Heim. Experientia. 1958 Mar 15;14(3):107–109. doi: 10.1007/BF02159243. [DOI] [PubMed] [Google Scholar]
- Hyde C., Glancy G., Omerod P., Hall D., Taylor G. S. Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. Br J Psychiatry. 1978 Jun;132:602–604. doi: 10.1192/bjp.132.6.602. [DOI] [PubMed] [Google Scholar]
- ISBELL H. Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia. 1959;1:29–38. doi: 10.1007/BF00408109. [DOI] [PubMed] [Google Scholar]
- MALITZ S., ESECOVER H., WILKENS B., HOCH P. H. Some observations on psilocybin, a new hallucinogen, in volunteer subjects. Compr Psychiatry. 1960 Feb;1:8–17. doi: 10.1016/s0010-440x(60)80045-4. [DOI] [PubMed] [Google Scholar]
- Mills P. R., Lesinskas D., Watkinson G. The danger of hallucinogenic mushrooms. Scott Med J. 1979 Oct;24(4):316–317. doi: 10.1177/003693307902400413. [DOI] [PubMed] [Google Scholar]
- RINKEL M., ATWELL C. R., DIMASCIO A., BROWN J. Experimental psychiatry. V. Psilocybine, a new psychotogenic drug. N Engl J Med. 1960 Feb 11;262:295–297. doi: 10.1056/NEJM196002112620606. [DOI] [PubMed] [Google Scholar]